JP2021527128A5 - - Google Patents
Info
- Publication number
- JP2021527128A5 JP2021527128A5 JP2021518056A JP2021518056A JP2021527128A5 JP 2021527128 A5 JP2021527128 A5 JP 2021527128A5 JP 2021518056 A JP2021518056 A JP 2021518056A JP 2021518056 A JP2021518056 A JP 2021518056A JP 2021527128 A5 JP2021527128 A5 JP 2021527128A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- product according
- pharmaceutical product
- mkh2
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024043503A JP7847880B2 (ja) | 2018-06-08 | 2024-03-19 | 組織石灰化を予防または治療するための方法および組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862682796P | 2018-06-08 | 2018-06-08 | |
| US62/682,796 | 2018-06-08 | ||
| PCT/US2019/036138 WO2019237053A1 (en) | 2018-06-08 | 2019-06-07 | Methods and compositions for preventing or treating tissue calcification |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024043503A Division JP7847880B2 (ja) | 2018-06-08 | 2024-03-19 | 組織石灰化を予防または治療するための方法および組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021527128A JP2021527128A (ja) | 2021-10-11 |
| JP2021527128A5 true JP2021527128A5 (enExample) | 2022-06-10 |
Family
ID=68765387
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021518056A Pending JP2021527128A (ja) | 2018-06-08 | 2019-06-07 | 組織石灰化を予防または治療するための方法および組成物 |
| JP2024043503A Active JP7847880B2 (ja) | 2018-06-08 | 2024-03-19 | 組織石灰化を予防または治療するための方法および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024043503A Active JP7847880B2 (ja) | 2018-06-08 | 2024-03-19 | 組織石灰化を予防または治療するための方法および組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (8) | US10688064B2 (enExample) |
| EP (1) | EP3801477A4 (enExample) |
| JP (2) | JP2021527128A (enExample) |
| KR (1) | KR20210018423A (enExample) |
| CN (1) | CN113038940A (enExample) |
| AU (1) | AU2019282420B2 (enExample) |
| CA (1) | CA3102977A1 (enExample) |
| IL (1) | IL279245B2 (enExample) |
| MX (2) | MX2020013302A (enExample) |
| SG (1) | SG11202012070YA (enExample) |
| WO (1) | WO2019237053A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019237054A1 (en) | 2018-06-08 | 2019-12-12 | Epizon Pharma, Inc. | Methods and compositions for preventing or treating calciphylaxis |
| IL279245B2 (en) | 2018-06-08 | 2024-03-01 | Epizon Pharma Inc | Compositions comprising menaquinone-7 (mk-7) and/or menquinol for prophylaxis of tissue calcification |
| WO2020055678A1 (en) | 2018-09-12 | 2020-03-19 | Epizon Pharma, Inc. | Menaquinol compositions and methods of treatment |
| MX2021010977A (es) * | 2019-03-12 | 2021-12-10 | Nattopharma As | Uso de vitamina k en combinacion con anticoagulantes. |
| KR20240045216A (ko) * | 2021-07-05 | 2024-04-05 | 위니베르시테이트 마스트리흐트 | 칼슘 결정 침착 질환의 치료 수단 및 방법 |
| WO2023129413A1 (en) * | 2021-12-31 | 2023-07-06 | Ingredient Fusion, Llc | Molecular complexing method, formulation and manufacturing for enhanced nutrient delivery |
| WO2024071848A1 (ko) * | 2022-09-27 | 2024-04-04 | 경북대학교 산학협력단 | 혈관석회화 치료제 스크리닝 방법 |
| WO2025075468A1 (ko) * | 2023-10-06 | 2025-04-10 | 주식회사 레드엔비아 | 혈관 또는 판막 협착증의 예방 또는 치료용 병용제제 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050176778A1 (en) | 2001-08-03 | 2005-08-11 | Vitak Bv | Isoprenyl derivatives and their use in the title treatment and prevention of osteoporosis and cardiovascular calcification |
| WO2005030190A1 (en) * | 2003-09-26 | 2005-04-07 | Natural Asa | Natural menaquinone 7 compositions |
| SI1728507T1 (sl) | 2005-06-03 | 2011-07-29 | Nattopharma Asa | Uporaba vitamina K za reverziranje kalcifikacije krvnih Ĺľil |
| EP2046312B1 (en) * | 2006-07-14 | 2020-02-19 | Kaydence Pharma AS | Pharmaceutical and nutraceutical products comprising vitamin k2 |
| GB0817528D0 (en) | 2008-09-24 | 2008-10-29 | Syntavit As | Process |
| WO2012059942A2 (en) | 2010-11-01 | 2012-05-10 | Viridis Biopharma Pvt. Ltd | Dynamic balancing of autonomic nervous system through vitamin mk-7 |
| GB201203705D0 (en) | 2012-03-02 | 2012-04-18 | Kappa Bioscience As | Prodrugs |
| ES2869202T3 (es) | 2012-06-18 | 2021-10-25 | Fresenius Kabi Deutschland Gmbh | Sistema de cánula para vía para la punción de vías centrales de acceso subcutáneo |
| WO2014191466A1 (en) | 2013-05-28 | 2014-12-04 | Nattopharma Asa | Menaquinone supplementation and vascular health |
| GB201314245D0 (en) | 2013-08-08 | 2013-09-25 | Kappa Bioscience As | Provitamins |
| WO2016131993A2 (en) * | 2015-02-20 | 2016-08-25 | Vitak B.V. | Vitamin k and capillary function |
| MX2017011934A (es) | 2015-03-20 | 2018-02-09 | Gnosis Spa | Formas solidas de menaquinoles. |
| IT201700085412A1 (it) | 2017-07-26 | 2019-01-26 | Pharmanutra S P A | Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare |
| US10368858B1 (en) | 2018-01-25 | 2019-08-06 | Ring Orthopedics, Inc. | Suture passer |
| WO2019237054A1 (en) | 2018-06-08 | 2019-12-12 | Epizon Pharma, Inc. | Methods and compositions for preventing or treating calciphylaxis |
| IL279245B2 (en) | 2018-06-08 | 2024-03-01 | Epizon Pharma Inc | Compositions comprising menaquinone-7 (mk-7) and/or menquinol for prophylaxis of tissue calcification |
-
2019
- 2019-06-07 IL IL279245A patent/IL279245B2/en unknown
- 2019-06-07 US US16/435,241 patent/US10688064B2/en active Active
- 2019-06-07 EP EP19814212.7A patent/EP3801477A4/en active Pending
- 2019-06-07 KR KR1020217000120A patent/KR20210018423A/ko not_active Ceased
- 2019-06-07 SG SG11202012070YA patent/SG11202012070YA/en unknown
- 2019-06-07 CA CA3102977A patent/CA3102977A1/en active Pending
- 2019-06-07 MX MX2020013302A patent/MX2020013302A/es unknown
- 2019-06-07 CN CN201980052695.9A patent/CN113038940A/zh active Pending
- 2019-06-07 JP JP2021518056A patent/JP2021527128A/ja active Pending
- 2019-06-07 WO PCT/US2019/036138 patent/WO2019237053A1/en not_active Ceased
- 2019-06-07 AU AU2019282420A patent/AU2019282420B2/en active Active
-
2020
- 2020-03-12 US US16/817,347 patent/US10874623B2/en active Active
- 2020-03-12 US US16/817,374 patent/US10744102B2/en active Active
- 2020-03-12 US US16/817,363 patent/US10744101B2/en active Active
- 2020-11-20 US US17/100,256 patent/US11033515B2/en active Active
- 2020-12-07 MX MX2024013515A patent/MX2024013515A/es unknown
-
2021
- 2021-05-11 US US17/317,488 patent/US11723882B2/en active Active
-
2023
- 2023-06-29 US US18/215,989 patent/US12377060B2/en active Active
-
2024
- 2024-03-19 JP JP2024043503A patent/JP7847880B2/ja active Active
-
2025
- 2025-06-12 US US19/236,367 patent/US20250302772A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021527128A5 (enExample) | ||
| JP2021527129A5 (enExample) | ||
| Shek et al. | Statin—fibrate combination therapy | |
| Kurban et al. | Cutaneous manifestations of chronic kidney disease | |
| Wang et al. | Effects of atorvastatin on chronic subdural hematoma: a preliminary report from three medical centers | |
| JP2022554020A5 (enExample) | ||
| Sauder et al. | Neovastat (AE-941), an inhibitor of angiogenesis: Randomized phase I/II clinical trial results in patients with plaque psoriasis | |
| JP7578243B2 (ja) | アルカリ性化剤による血液浄化 | |
| JP2016538277A5 (enExample) | ||
| CN113038940A (zh) | 用于预防或治疗组织钙化的方法和组合物 | |
| Hiramoto et al. | Evidence-based analysis: postoperative gastric bleeding: etiology and prevention | |
| Wang et al. | Combined low-dose aspirin and warfarin anticoagulant therapy of postoperative atrial fibrillation following mechanical heart valve replacement | |
| JP2018516931A5 (enExample) | ||
| RU2447913C1 (ru) | Способ лечения местнораспространенного рака молочной железы с опухолевыми изъязвлениями кожи | |
| Qian et al. | Effect of Pingchuan Guben decoction on patients with chronic obstructive pulmonary disease: Results from a randomized comparative effectiveness research trial | |
| EP3969110A1 (en) | Compositions comprising 15-hepe and/or 15-hetre and methods of treating or preventing cardiometabolic disease, metabolic syndrome, and/or related diseases | |
| RU2465905C2 (ru) | Способ замедления преждевременного старения у работников газодобывающего предприятия | |
| JP6184960B2 (ja) | メラトニンの新規用途 | |
| Yahya et al. | Old drug with new milestone: chloroquine and hydroxychloroquine in SARS-COV-2 (COVID-19) with multifaceted effects in other diseases | |
| WO2017180259A1 (en) | Methods for treating nsaid-induced cardiovascular, cerebrovascular, or renovascular adverse events | |
| ROCHA et al. | Functional nutrition in postoperative plastic surgery: focus on seroma and fibrosis prevention | |
| Ballantyne et al. | 1084-176 Efficacy of ezetimibe coadministered with simvastatin versus atorvastatin in patients with hypercholesterolemia | |
| HINT | FICA: Taking a Spiritual History | |
| CN101766618A (zh) | 匹伐他汀钙的新用途以及针对新用途的药物 | |
| Breijo-Marquez | Inadequate Use of the Drug Acenocoumarol in Non-Valvular Atrial Fibrillation |